# What are the most effective patent trial and appeal board defense strategies for patent owners facing inter partes review in 2026?

patentreviewpro.com · October 17, 2026

> Understanding the Modern PTAB Defense Landscape The Patent Trial and Appeal Board has undergone substantial transformation in recent years, and patent...

## Understanding the Modern PTAB Defense Landscape

The Patent Trial and Appeal Board has undergone substantial transformation in recent years, and patent owners must adapt their defense strategies accordingly. As of mid-2026, the USPTO has implemented new institutional factors that directly affect whether a petition for inter partes review will be granted, including domestic manufacturing considerations and small business status. These changes create both opportunities and obstacles for patent owners seeking to preserve their patent portfolios against challenge. The board's evolving approach to patent eligibility under Section 101 has also shifted, with recent signals indicating reduced hurdles for inventions involving artificial intelligence and other emerging technologies. Patent owners who understand these shifts can position their defenses more effectively and avoid the common trap of assuming that prior strategies will succeed in the current procedural environment.

**Also worth reading:** [Can Physical AI Patent Portfolios Unlock New Capital Strategies for Autonomous Systems Companies?](https://patentreviewpro.com/knowledge/can_physical_ai_patent_portfolios_unlock_new_capital_strategies_for_autonomous_systems_companies.php) · [How Are AI Patent Eligibility Trends Reshaping Global Innovation Strategies?](https://patentreviewpro.com/knowledge/how_are_ai_patent_eligibility_trends_reshaping_global_innovation_strategies.php) · [How Can Responsible AI Patent Filing Strategies Protect High-Stakes Innovations?](https://patentreviewpro.com/knowledge/how_can_responsible_ai_patent_filing_strategies_protect_high-stakes_innovations.php)

## The Impact of Recent USPTO Policy Changes on PTAB Proceedings

A new USPTO memorandum issued in 2026 added domestic manufacturing and small business factors to the institution analysis for inter partes review petitions, fundamentally altering how the board weighs whether to take up a challenge. This memorandum means that petitions targeting patents held by small entities or those with domestic manufacturing operations may face higher institutional thresholds, giving patent owners a potential avenue for early dismissal. At the same time, the USPTO has proposed dramatic restrictions on patent challenges through inter partes review, which could limit the number of petitions a single petitioner can file or narrow the scope of claims subject to review. These restrictions reflect a broader rebalancing of patent rights that has been accelerated by political and economic pressures, including high-profile deals involving major technology companies and their patent portfolios. Patent owners should monitor these policy developments closely, as they can change the calculus of whether to settle or fight a challenge at the board.

## Building a Robust Written Response Strategy

The written response to a petition for inter partes review remains the first and most critical line of defense, and patent owners must treat it with the same rigor as a briefing in federal litigation. A strong response typically includes detailed claim construction arguments, evidence of commercial success, and expert declarations that address each real-world connection cited in the petition. The board has increasingly scrutinized the quality of patent owner responses, and submissions that rely on boilerplate language or fail to address the specific grounds of unpatentability are more likely to result in institution even when the patent has merit. In 2026, the board has also placed greater weight on whether the patent owner can demonstrate that the claimed invention would have been obvious in light of the prior art, making it essential to present a coherent narrative that ties together secondary considerations and technical distinctions. Patent owners should allocate sufficient resources to prepare a thorough response, as the decision to institute review is often made based on the initial papers alone.

## Comparing Defense Options: Settlement, Amendment, and Trial

Patent owners facing inter partes review have several paths available, each with distinct advantages and risks that must be weighed carefully. The table below summarizes the key characteristics of the primary defense strategies available at the PTAB as of 2026.

| Defense Strategy | Typical Timeline | Cost Range | Success Rate | Best For |
| --- | --- | --- | --- | --- |
| Settlement with petitioner | 3-6 months | $50,000-$250,000 | High (avoids board decision) | Weak claims, high litigation risk |
| Claim amendment during response | 6-12 months | $75,000-$300,000 | Moderate | Strong claims with clear amendment paths |
| Full trial on merits | 12-18 months | $300,000-$1,000,000+ | Variable | Strong patents with clear prior art distinctions |
| Request for rehearing or appeal | 6-12 months additional | $100,000-$400,000 | Low to moderate | Procedural errors or significant legal mistakes |

Settlement has become an increasingly common outcome, particularly in cases where the petitioner has significant financial resources and the patent owner faces parallel litigation. Amendment strategies can succeed when the patent owner identifies clear claim distinctions that survive the broadest reasonable interpretation standard applied by the board, but amendments must be carefully crafted to avoid introducing new matter or narrowing claims in ways that undermine their commercial value. Full trials on the merits remain the most expensive option but can preserve patent validity for the long term, especially when the patent owner presents compelling expert testimony and documentary evidence. Appeals to the Federal Circuit are costly and uncertain, with reversal rates that have remained relatively low, making this option most appropriate for cases involving significant legal errors rather than factual disputes.

## Common Mistakes Patent Owners Make at the PTAB

One of the most frequent errors patent owners make is failing to respond to a petition within the strict deadlines imposed by the board, which can result in default institution and loss of the opportunity to present arguments before the trial begins. Another common mistake is relying too heavily on declarations that merely restate the patent specification without providing new technical evidence or expert analysis that addresses the specific grounds of unpatentability raised in the petition. Many patent owners also underestimate the importance of claim construction arguments in their written response, treating the response as a simple assertion of validity rather than a detailed legal brief that anticipates the board's analysis. Some owners attempt to amend claims too late in the process or propose amendments that are so narrow they effectively surrender the commercial value of the patent. Finally, failing to consider the interplay between PTAB proceedings and parallel district court litigation can lead to strategic missteps, such as making admissions during board proceedings that are then used against the patent owner in court.

## When to Act and How to Allocate Resources

Patent owners should begin preparing their defense strategy as soon as they receive notice of a petition for inter partes review, since the institution decision often hinges on the initial response and the window for effective action is narrow. Early engagement with experienced PTAB counsel allows patent owners to assess the strength of the petitioner's case, identify the most vulnerable claims, and develop a timeline that aligns with parallel litigation or licensing negotiations. Resource allocation should prioritize the written response and any claim amendments, as these stages offer the greatest opportunity to shape the proceeding before the board commits significant institutional resources to a full trial. Patent owners with portfolios that include artificial intelligence patents should pay particular attention to the board's evolving approach to Section 101 eligibility, as recent decisions have signaled greater tolerance for AI-related inventions that might have been rejected under earlier standards. The cost of defending a single inter partes review can range from $150,000 to over $1 million depending on the complexity of the technology and the number of claims at issue, making it essential for patent owners to evaluate the commercial value of the patent and the likelihood of success before committing to a full trial.

## The Role of AI and Emerging Technologies in PTAB Defense

The intersection of artificial intelligence and patent law has introduced new dimensions to PTAB defense strategy, particularly as the board has begun to signal greater receptivity to AI-related inventions. Recent decisions have reduced Section 101 hurdles for inventions that involve machine learning algorithms, neural network architectures, and other AI-specific technologies, giving patent owners in this space a stronger foundation for defending their patents. However, the USPTO has also codified restrictions on the patentability of patents credited solely to AI authors, which means that patents with human inventors who used AI tools as part of the inventive process must carefully document the human contribution to avoid validity challenges. Patent owners should ensure that their specifications and prosecution histories clearly articulate the human inventive concept and the specific technical contribution of any AI components used in the invention. As AI continues to reshape industries from semiconductors to pharmaceuticals, the PTAB's approach to these technologies will likely evolve further, and patent owners must stay informed about emerging precedents that could affect their defense strategies.

## Strategic Considerations for Large Patent Holders and Technology Companies

Large technology companies and patent portfolios face unique challenges at the PTAB, particularly when their patents are targeted by well-funded petitioners or competing entities seeking to clear the path for their own products. Intel's recent dealings with the Trump administration have highlighted how political and economic factors can intersect with patent defense strategies, creating additional uncertainty for companies that rely on their patent portfolios for competitive advantage. The 2026 Lawdragon 500 Leading Global IP Lawyers list reflects the growing specialization of patent practice, with top firms and attorneys increasingly focused on PTAB proceedings and the strategic management of patent portfolios through trial and appeal. Companies should consider developing a comprehensive PTAB defense playbook that includes pre-emptive claim amendments, proactive monitoring of potential petitioners, and coordination between litigation counsel and prosecution teams to ensure consistency across proceedings. The cost of maintaining a strong patent portfolio through active defense at the PTAB can be substantial, but the alternative of losing key patents to inter partes review can be far more damaging to a company's market position and licensing revenue.

## Quick answers

### What is the difference between inter partes review and other PTAB proceedings?

Inter partes review is a post-grant proceeding where a third party can challenge the validity of patent claims based on prior patents and printed publications. Unlike ex parte reexamination, which is initiated by the patent owner, IPR is petitioner-driven and follows a more streamlined discovery and claim construction process. The Patent Trial and Appeal Board conducts both proceedings, but IPR has become the most common mechanism for challenging patent validity.

### How long does a PTAB trial typically last?

A full trial on the merits at the PTAB typically lasts between 12 and 18 months from institution to final written decision, though complex cases involving multiple claims or technologies can take longer. The board has proposed rules that could extend or compress timelines depending on the number of claims challenged and the complexity of the technology.

### Can a patent owner amend claims during an inter partes review?

Yes, patent owners can amend claims during their written response or during the trial phase, but amendments must be carefully drafted to avoid introducing new matter and must demonstrate that the amended claims are patentable over the prior art cited in the petition. The board applies a broadest reasonable interpretation standard to amended claims, which can make it difficult to preserve the full scope of the original patent.

### What are the costs associated with defending an inter partes review?

Defending an IPR can cost between $150,000 and over $1 million depending on the complexity of the technology, the number of claims at issue, and whether the case proceeds to a full trial. Settlement costs are typically lower, ranging from $50,000 to $250,000, while appeals to the Federal Circuit add additional expense and time.

### How has the USPTO changed its approach to AI patents at the PTAB?

The PTAB has signaled reduced Section 101 hurdles for AI inventions in recent decisions, reflecting a broader shift in how the board evaluates patent eligibility for technology involving machine learning and neural networks. However, patents credited solely to AI authors face restrictions, and patent owners must clearly document the human inventive contribution when AI tools are used in the invention process.

Canonical: https://patentreviewpro.com/knowledge/what_are_the_most_effective_patent_trial_and_appeal_board_defense_strategies_for_patent_owners_facing_inter_partes_review_in_2026.php
Markdown: https://patentreviewpro.com/knowledge/what_are_the_most_effective_patent_trial_and_appeal_board_defense_strategies_for_patent_owners_facing_inter_partes_review_in_2026.php/index.md